Back to Results
First PageMeta Content
United States securities law / Occupations / Securities / Securities research / Investment banking / Financial analyst / Short / Target price / Financial Industry Regulatory Authority / Finance / Business / Financial economics


Document Date: 2014-05-04 04:03:19

Open Document

File Size: 127,16 KB

Share Result on Facebook

City

New York / /

Company

IMPORTANT DISCLOSURES / Pluristem Therapeutics Inc. / Investment Research Pluristem Therapeutics Inc. / Financial Metrics EPS Pluristem Therapeutics Inc. / MLV & Co LLC / /

Continent

Americas / /

Country

United States / South Korea / /

Currency

USD / /

/

Event

Earnings Guidance / /

IndustryTerm

execution services / state-of-theart manufacturing facility / sustainable commercial-scale solution / manufacturing facilities / manufacturing platform / investment banking revenues / investment banking services / cell manufacturing / /

Organization

United States Senate / National Institute of Health / Israel Ministry of Economy / FDA / Alliance for Regenerative Medicine / Federal Deposit Insurance Corporation / European Union / SIPC / FINRA / /

Person

Randy Billhardt / Vernon T. Bernardino / Grant - Reiterate Our / Alec Taliaferro / Brian M. Dorst / /

/

Position

Analyst Certification The research analyst / tax advisor / Chief Scientist / Additional Disclosures The analyst / research analyst / Analyst / /

ProvinceOrState

New York / /

Technology

cell therapy / Biotechnology / Regenerative Medicine / /

SocialTag